Literature DB >> 8355686

Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain.

Z E Wang1, G M Myles, C S Brandt, M N Lioubin, L Rohrschneider.   

Abstract

The c-fms gene encodes the receptor for the macrophage colony-stimulating factor (M-CSF), and its extracellular domain consists of five immunoglobulin-like subdomains. To identify which of the five immunoglobulin-like regions are involved in ligand binding, we polymerase chain reaction-cloned five segments of the extracellular domain of the murine c-fms gene, each starting with the normal initiation codon and containing successive additions of the immunoglobulin-like subdomains. These protein segments are designated A, B, C, D, and E and contain, from the N-terminal end, either one, two, three, four, or all five immunoglobulin-like subdomains, respectively. Each segment was expressed as a secreted soluble protein from a baculovirus expression vector in Sf9 insect cells. In addition, segments A, B, C, and E were produced as soluble alkaline phosphatase fusion proteins, as was a segment containing only the fourth and fifth immunoglobulin domains. These segments of the Fms extracellular domain were used to assess M-CSF binding by competition radioimmunoassays, plate binding immunoassays, and immunoprecipitation analyses. The results indicated that the first two N-terminal immunoglobulin-like domains did not interact with M-CSF but, in combination with the third immunoglobulin-like domain, provided high-affinity M-CSF binding. The fourth and fifth immunoglobulin-like domains near the cell membrane did not exhibit M-CSF binding and may inhibit interaction of M-CSF with the first three immunoglobulin domains. These results suggest that the three N-terminal immunoglobulin-like domains constitute the high-affinity M-CSF binding region and that the fourth and fifth immunoglobulin-like domains may perform functions other than ligand binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355686      PMCID: PMC360234          DOI: 10.1128/mcb.13.9.5348-5359.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus.

Authors:  C F Ockenhouse; R Betageri; T A Springer; D E Staunton
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

2.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

Authors:  D P Gearing; M R Comeau; D J Friend; S D Gimpel; C J Thut; J McGourty; K K Brasher; J A King; S Gillis; B Mosley
Journal:  Science       Date:  1992-03-13       Impact factor: 47.728

3.  Murine c-fms cDNA: cloning, sequence analysis and retroviral expression.

Authors:  V M Rothwell; L R Rohrschneider
Journal:  Oncogene Res       Date:  1987 Sep-Oct

4.  Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae.

Authors:  J Umemoto; V P Bhavanandan; E A Davidson
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

5.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

6.  Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.

Authors:  R Sacca; E R Stanley; C J Sherr; C W Rettenmier
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  Expression cloning of a receptor for murine granulocyte colony-stimulating factor.

Authors:  R Fukunaga; E Ishizaka-Ikeda; Y Seto; S Nagata
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

8.  Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1.

Authors:  J Stein; G V Borzillo; C W Rettenmier
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

9.  Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development.

Authors:  R J Arceci; F Shanahan; E R Stanley; J W Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential.

Authors:  M F Roussel; J R Downing; C W Rettenmier; C J Sherr
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

View more
  20 in total

1.  Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling.

Authors:  R P Bourette; G M Myles; J L Choi; L R Rohrschneider
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

2.  Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases.

Authors:  Heli Liu; Xiaoyan Chen; Pamela J Focia; Xiaolin He
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

3.  A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation.

Authors:  Ying Xiong; Da Song; Yunfei Cai; Wenfeng Yu; Yee-Guide Yeung; E Richard Stanley
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

4.  The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

Authors:  L D Strockbine; J I Cohen; T Farrah; S D Lyman; F Wagener; R F DuBose; R J Armitage; M K Spriggs
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.

Authors:  Z Wang; H Jiang; Z Q Yang; S Chacko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 6.  Cytokine mediators of chronic graft-versus-host disease.

Authors:  Kelli Pa MacDonald; Bruce R Blazar; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2017-06-30       Impact factor: 14.808

7.  Overexpression, purification, and characterization of full-length and mutant caldesmons using a baculovirus expression system.

Authors:  Z Wang; K Y Horiuchi; S S Jacob; S Gopalakurup; S Chacko
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

Review 8.  Macrophage colony-stimulating factor and cancer: a review.

Authors:  S Chockalingam; Siddhartha Sankar Ghosh
Journal:  Tumour Biol       Date:  2014-09-20

9.  Mona, a novel hematopoietic-specific adaptor interacting with the macrophage colony-stimulating factor receptor, is implicated in monocyte/macrophage development.

Authors:  R P Bourette; S Arnaud; G M Myles; J P Blanchet; L R Rohrschneider; G Mouchiroud
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

10.  Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice.

Authors:  Trevor Lucas; Dietmar Abraham; Gerold Untergasser; Karin Zins; Erhard Hofer; Eberhard Gunsilius; Seyedhossein Aharinejad
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.